These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13603976)

  • 1. [Late cellular changes following actions of mitotic poisons; observations on tissue cultures].
    SCHNEWEIS KE
    Virchows Arch Pathol Anat Physiol Klin Med; 1958; 331(3):249-62. PubMed ID: 13603976
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of mitotic poisons on the hyperdiploid Ehrlich ascites carcinoma.
    LETTRE H
    Ann N Y Acad Sci; 1958 Dec; 76(3):556-71. PubMed ID: 13627883
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytological assay of c-mitotic and prophase poison actions.
    HADDER JC; WILSON GB
    Chromosoma; 1958; 9(2):91-104. PubMed ID: 13537263
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of mitotic poisons on the development of Trichomonas vaginalis in culture].
    ORLOWSKA B; MORDARSKI M
    Wiad Parazytol; 1962; 8():197-200. PubMed ID: 14482298
    [No Abstract]   [Full Text] [Related]  

  • 5. [On therapy with chemically effective cell poisons].
    FROHBERG H; OETTEL H; WILHELM G
    Strahlentherapie; 1959; Suppl 43():260-4. PubMed ID: 13825324
    [No Abstract]   [Full Text] [Related]  

  • 6. [On synergists of mitosis poisons. Part 14].
    LETTRE H
    Chemotherapia (Basel); 1960; 1():112-9. PubMed ID: 14416090
    [No Abstract]   [Full Text] [Related]  

  • 7. Past and future of the mitotic spindle as an oncology target.
    Wood KW; Cornwell WD; Jackson JR
    Curr Opin Pharmacol; 2001 Aug; 1(4):370-7. PubMed ID: 11710735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytostatic drugs. 2: Bleomycins, antimetabolites, mitotic spindle poisons, L-asparaginase and anti-hormones].
    Bauch HJ
    Med Monatsschr Pharm; 1989 Feb; 12(2):34-45. PubMed ID: 2466194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Poisons of DNA topoisomerases I and II].
    Charcosset JY; Soues S; Laval F
    Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracerebral application of mitotic poisons in the electric field].
    ROEDER F
    Dtsch Z Nervenheilkd; 1951; 166(3):189-95. PubMed ID: 14936710
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of mitotic poisons on the development of Protozoa].
    ORLOWSKA B; MORDARSKI M
    Arch Immunol Ther Exp (Warsz); 1960; 8():565-91. PubMed ID: 13731216
    [No Abstract]   [Full Text] [Related]  

  • 12. [INTRAMURAL ADMINSTRATION OF MITOTIC POISONS BEFORE GASTECTOMY (EXPERIMENTAL STUDIES IN DOGS)].
    KOSZAROWSKI T; MEYZA J; ROSNOWSKI A; JARMOLOWICZ J; KOLODZIEJSKI T
    Nowotwory; 1964; 14():201-6. PubMed ID: 14245665
    [No Abstract]   [Full Text] [Related]  

  • 13. Topoisomerase-targeting antitumor drugs.
    D'Arpa P; Liu LF
    Biochim Biophys Acta; 1989 Dec; 989(2):163-77. PubMed ID: 2557085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of colchiceine amides on cells in vitro and in vivo].
    LETTRE H
    Experientia; 1954 Jun; 10(6):271. PubMed ID: 13183074
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytological observations on tumor cells under the effect of mitotic poisons].
    GROPP H
    Z Krebsforsch; 1954; 60(1):9-15. PubMed ID: 13227204
    [No Abstract]   [Full Text] [Related]  

  • 16. Some observations on the cytological effects of antimitotic poisons.
    Dustin P
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):182-4. PubMed ID: 5659726
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA sequence selectivity of topoisomerases and topoisomerase poisons.
    Capranico G; Binaschi M
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):185-94. PubMed ID: 9748568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of carcinogens and mitotic poisons tested on bacterial cultures].
    SIRTORI C; PARVIS D; PIZZETTI F
    Acta Unio Int Contra Cancrum; 1955; 11(6):712-4. PubMed ID: 13326680
    [No Abstract]   [Full Text] [Related]  

  • 19. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Holm B; Jensen PB; Sehested M
    Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.